Surgical Science Sweden AB (publ) (FRA:4P41)

Market Cap	130.87M -80.5%
Revenue (ttm)	88.19M +13.4%
Net Income	6.32M -63.9%
EPS	0.12 -63.9%
Shares Out	n/a
PE Ratio	20.72
Forward PE	11.13
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Average Volume	250
Open	2.530
Previous Close	2.600
Day's Range	2.526 - 2.580
52-Week Range	2.510 - 17.220
Beta	n/a
RSI	27.38
Earnings Date	Feb 19, 2026

About FRA:4P41

Surgical Science Sweden AB (publ) develops and markets virtual reality simulators for evidence-based medical training in Europe, North and South America, Asia, and internationally. The company offers Angio Mentor simulator for endovascular training; BRONCH Express, a portable version of BRONCH mentor simulator; ARTHRO Mentor for arthroscopic surgery skills acquisition; BRONCH Mentor, a simulator for optimizing bronchoscopy training; GI Mentor, a simulator for GI Endoscopy; HYST Mentor for True-To-Life diagnostic and therapeutic hysteroscopy tra...

• Industry: Electromedical and Electrotherapeutic Apparatus
• Founded: 1997
• Employees: 328
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: 4P41

Financial Performance

In 2024, FRA:4P41's revenue was 884.09 million, an increase of 0.14% compared to the previous year's 882.85 million. Earnings were 131.65 million, a decrease of -43.73%.

Financial numbers in SEK